Oxford BioMedica forms alliance with AstraZeneca

Oxford BioMedica (LSE:OXB) struck a genomics and target validation deal with AstraZeneca R&D (LSE:AZN; AZN). The companies will use OXB's LentiVector lentiviral gene delivery technology to deliver gen...